Vaxcyte, Inc. (PCVX)

Vaxcyte (PCVX) Stock Price & Analysis


PCVX Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$17.44 - $49.31
Previous Close$36.85
Average Volume (3M)661.09K
Market Cap
Enterprise Value$2.04B
Total Cash (Recent Filing)$931.38M
Total Debt (Recent Filing)$17.94M
Price to Earnings (P/E)-10.7
May 09, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.44
Shares Outstanding80,033,727
10 Day Avg. Volume806,823
30 Day Avg. Volume661,085
Standard Deviation0.20
Financial Highlights & Ratios
Price to Book (P/B)3.18
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-17.20
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-9.50
Price Target Upside75.08% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering6



Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Vaxcyte, Inc.’s price range in the past 12 months?
Vaxcyte, Inc. lowest stock price was $17.44 and its highest was $49.31 in the past 12 months.
    What is Vaxcyte, Inc.’s market cap?
    Currently, no data Available
    When is Vaxcyte, Inc.’s upcoming earnings report date?
    Vaxcyte, Inc.’s upcoming earnings report date is May 09, 2023 which is in 39 days.
      How were Vaxcyte, Inc.’s earnings last quarter?
      Vaxcyte, Inc. released its earnings results on Feb 27, 2023. The company reported -$1.03 earnings per share for the quarter, missing the consensus estimate of -$0.93 by -$0.1.
        Is Vaxcyte, Inc. overvalued?
        According to Wall Street analysts Vaxcyte, Inc.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Vaxcyte, Inc. pay dividends?
          Vaxcyte, Inc. does not currently pay dividends.
          What is Vaxcyte, Inc.’s EPS estimate?
          Vaxcyte, Inc.’s EPS estimate is -$0.83.
            How many shares outstanding does Vaxcyte, Inc. have?
            Vaxcyte, Inc. has 80,033,730 shares outstanding.
              What happened to Vaxcyte, Inc.’s price movement after its last earnings report?
              Vaxcyte, Inc. reported an EPS of -$1.03 in its last earnings report, missing expectations of -$0.93. Following the earnings report the stock price went down -3.144%.
                Which hedge fund is a major shareholder of Vaxcyte, Inc.?
                Among the largest hedge funds holding Vaxcyte, Inc.’s share is RA Capital Management. It holds Vaxcyte, Inc.’s shares valued at 281M.


                  Vaxcyte Stock Smart Score

                  The Vaxcyte stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Vaxcyte, Inc.

                  Vaxcyte Inc is a vaccine company seeking to improve global health by developing novel vaccines to treat patients suffering from most common and deadly diseases.


                  Top 5 ETFs holding PCVX

                  Market Value
                  Smart Score
                  Fidelity Nasdaq Composite Index ETF
                  Fidelity Growth Opportunities ETF
                  Up to five ETFs with an Outperform Smart Score that hold PCVX. The ETFs are listed according to market value of PCVX within the ETF


                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  Intellia Therapeutics
                  Vir Biotechnology

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis